Dr. Xiuchun Chen 陈秀春
Chief Physician
Department of Breast Surgery, Henan Cancer Hospital, Zhengzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of breast tumors, including early detection and standardized comprehensive therapy for breast cancer. Specializes in breast-conserving surgery, sentinel lymph node biopsy, and breast reconstruction.
Dr. Chen is a Chief Physician at Henan Cancer Hospital. The doctor focuses on the diagnosis and treatment of breast tumors, with expertise in early detection and standardized comprehensive therapy for breast cancer. Dr. Chen specializes in breast-conserving surgery, sentinel lymph node biopsy, and breast reconstruction.
Professional roles
- Standing Committee Member, Breast Disease Professional Committee, China Association for Promotion of Traditional Chinese Medicine Research
- Standing Committee Member, Breast Cancer Group, Precision Medicine and MDT Professional Committee, Chinese Research Hospital Association
- Member, Breast Disease Training Professional Committee, Chinese Medical Doctor Association
Name order: in Chinese the family name comes first (Chen Xiuchun). Papers usually list the name as Xiuchun Chen or Chen X.
Selected publications
35 papers on PubMed matched by name and affiliation; 4 as first or senior author since 2016. Most recent first- or senior-author papers:
- Lancet Oncol, 2025 (first author): De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab versus docetaxel, carboplatin, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer (HELEN-006): a multicentre, randomised, phase 3 trial. PubMed 39612919
- Chin Med J (Engl), 2024 (first author): Targeted axillary dissection after neoadjuvant chemotherapy for highly selective patients with initial cN1 breast cancer: A single-center prospective trial. PubMed 38557731
- Chin Med J (Engl), 2021 (senior author): Development and validation of a nomogram for predicting survival of breast cancer patients with ipsilateral supraclavicular lymph node metastasis. PubMed 34743149
- Cancer Manag Res, 2021 (senior author): Lymphocyte-to-Monocyte Ratio is Associated with the Poor Prognosis of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy. PubMed 33623436
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion